Related Experiment Videos
Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels
J Daut1, W Maier-Rudolph, N von Beckerath
1Physiologisches Institut der Technischen Universität München, Biedersteiner, Federal Republic of Germany.
Insights
Decreased oxygen causes coronary arteries to dilate, a process involving ATP-sensitive potassium channels. Blocking these channels prevents dilation, while opening them mimics the effect, highlighting their role in heart oxygen supply.
Area of Science:
- Cardiovascular Physiology
- Cellular Electrophysiology
Background:
- Heart function relies on oxygen supply via coronary arteries.
- Coronary arteries dilate in response to decreased oxygen tension.
- Adenosine triphosphate (ATP)-sensitive potassium channels are implicated in vascular tone regulation.
Purpose of the Study:
- To investigate the role of ATP-sensitive potassium channels in hypoxic vasodilation of the heart.
- To determine if modulating these channels affects coronary artery diameter under low oxygen conditions.
Main Methods:
- Utilized isolated, perfused guinea pig hearts.
- Administered glibenclamide (a blocker) and cromakalim (an opener) of ATP-sensitive potassium channels.
- Observed effects on coronary vasodilation under hypoxic conditions.
Main Results:
- Glibenclamide prevented hypoxic vasodilation in guinea pig hearts.
- Cromakalim mimicked hypoxic vasodilation.
- These findings suggest potassium channel activity is central to the response.
Conclusions:
- Opening of potassium channels in coronary smooth muscle cells is likely the primary mechanism for hypoxic and ischemic vasodilation in the mammalian heart.
- Modulation of ATP-sensitive potassium channels represents a potential target for managing coronary blood flow.
Abstract:
The function of the heart depends critically on an adequate oxygen supply through the coronary arteries. Coronary arteries dilate when the intravascular oxygen tension decreases. Hypoxic vasodilation in isolated, perfused guinea pig hearts can be prevented by glibenclamide, a blocker of adenosine triphosphate (ATP)-sensitive potassium channels, and can be mimicked by cromakalim, which opens ATP-sensitive potassium channels. Opening of potassium channels in coronary smooth muscle cells and the subsequent drop in intracellular calcium is probably the major cause of hypoxic and ischemic vasodilation in the mammalian heart.